SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

Never Miss a Story

Sign Up For Weekly Top Stories

 

More Industry Headlines

Tau PET imaging may be the key to developing effective drugs for Alzheimer’s Researchers continue to shift focus away from Amyloid

Non-contrast MR angiography safe for patients with renal disease and diabetes An alternative to gadolinium-based contrast agents?

PET/CT beats MR for assessing head and neck cancer treatment response Informing efficacy of chemo after a single round of treatment

Patient centering is key to CT dose optimization Retrospective studies have shown off-centering is most pronounced vertically

ASTRO 2016: the big news from radiation therapy's leading OEMs For improving dose delivery, image guidance is a clear priority

Blue Cross Blue Shield plans ACA exits in two states Will pull out of three markets in Tennessee and Nebraska in 2017

GE will invest $50 million into disruptive health care startups worldwide Launches accelerator five.eight to move the needle on global care

Roughly half of radiotherapy candidates in developing countries lack access: ASTRO It's a 'give a man a fish' problem

NSF awards grant to develop MR-guided robotic biopsies Guidabot designed for real-time imaging of minimally invasive neurological interventions

Boston Scientific to acquire EndoChoice for $210 million Expanding endoscopy presence as pacemakers and implanted defibrillator sales slow

Study backs CT colonography screenings in older patients

by Brendon Nafziger , DOTmed News Associate Editor
The Centers for Medicare and Medicaid Services shot down requests to cover virtual colonoscopies in 2009 citing, in part, a lack of evidence of the imaging technique for Medicare-aged patients. But a new study suggests it's as good at finding cancerous growths, and as safe, as it is in younger patients.

The study, published in the July issue of the American Journal of Roentgenology, examined records of 1,410 patients 65 years and up who underwent a screening or surveillance CT colonography -- that is, a CT scan of their gut to check for cancers or abnormal masses.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material, camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



The researchers said they were able to address a handful of CMS' published concerns about extending nationwide coverage to CTCs -- lack of evidence of their effectiveness in seniors, worries about ionizing radiation dose from the scans, and fears that the discovery of large numbers of "extracolonic findings," or potentially medically significant growths outside the colon, would lead to a lot of costly follow-up diagnostic tests.

Comparable evidence

First, the authors of the retrospective study, conducted at the National Naval Medical Center in Bethesda, Md., said the referral rates, or percentage of patients referred to a traditional colonoscopy after a scan, were reasonably low. Using what is apparently a standard 6-millimeter polyp cutoff size for referral, researchers said 14.5 percent of patients were referred for traditional optical colonoscopies (or 198 out of 1,364 patients, after 46 were excluded because of involvement in another clinical trial).

This is similar to what has been found in CTC studies of younger patients, and also similar to the rate found by other researchers for the 65 and over population. Two other CTC studies cited by the authors found between 14 and 15 percent colonoscopy referral rates in Medicare-age patients. And a recently published secondary analysis of the ACRIN National CT colonography Trial, one of the biggest-ever studies of CTC, estimated a hypothetical referral rate, based on their data, of at most 12.6 percent for the 65 and overs.

In the current study, abnormal growths, or neoplasia, were found in 9.3 percent of patients, and advanced neoplasia in 3.3 percent of the group, according to the researchers. These were also similar to findings in younger patients.

Extracolonic findings, a big sticking-point among CMS and other CTC skeptics, were seen in only 2.9 percent of patients, comparable to findings in younger patient cohorts, the researchers said. Extracolonic findings were mainly seen in the guts, the vascular system or in the lungs and surrounding areas.
  Pages: 1 - 2 >>

Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2016 DOTmed.com, Inc.
ALL RIGHTS RESERVED